After suffering the loss of a child to a rare congenital disorder and a brother to a chronic disease, Jeeva founder and CEO Dr. Harsha Rajasimha decided to apply his years of postdoctoral training at the National Institutes of Health and the U.S. Food and Drug Administration, as well as his work in the healthcare and life science industry, to accelerating access to treatments for rare & chronic diseases by eliminating bottlenecks in the clinical trials process.
Jeeva partners with clinical research sponsors to execute modern clinical trials with significant efficiency and cut costs using their innovative one-login unified software platform for end-to-end study execution. Jeeva eliminates the need for numerous point solutions and vendors, boosts efficiency for all users, a digital patient engagement portal, with one flat subscription fee solution with one login access to real-time data and monitoring dashboards. Jeeva is driven by AI and tech innovation to automate manual repetitive tasks and was purpose built using modern patient-centric technology stack. Jeeva delivers rapid and complete protocol configuration in 2-4 weeks, remote patient screening, eConsent, referral to investigator sites, randomization, electronic data capture, remote clinical outcomes assessments including patient reported outcomes, eDiaries, televisits or video visits, with a patient engagement portal, appointment booking and rescheduling, and much more under a single login for each stakeholder.